The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis-Reference-Cited by-同舟云学术

The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis

Published:2020-11 Issue: Volume:276 Page:576-584
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

McIntyre Roger S.,Carvalho Isabelle P.^ORCID,Lui Leanna M.W.,Majeed Amna,Masand Prakash S.,Gill Hartej,Rodrigues Nelson B.,Lipsitz Orly^ORCID,Coles Alexandria C.,Lee Yena,Tamura Jocelyn K.,Iacobucci Michelle,Phan Lee,Nasri Flora,Singhal Nikhita^ORCID,Wong Elizabeth R.,Subramaniapillai Mehala,Mansur Rodrigo,Ho Roger^ORCID,Lam Raymond W.^ORCID,Rosenblat Joshua D.

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference46 articles.

1. Ketamine's mechanism of action: a path to rapid-acting antidepressants;Abdallah;Depress. Anxiety,2016

2. Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial;Arabzadeh;J. Affect. Disord.,2018

3. Antidepressant effects of ketamine in depressed patients;Berman;Biol. Psychiatry,2000

4. Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study;Canuso;Am. J. Psychiatry,2018

5. Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: a randomized, double-blind control study;Chen;Psychiatry Res.,2018

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomised, open-label, pragmatic pilot comparison of oral and intravenous ketamine in treatment-resistant depression;Asian Journal of Psychiatry;2024-09

2. Catastrophic out-of-pocket payments related to non-communicable disease multimorbidity and associated factors, evidence from a public referral hospital in Addis Ababa Ethiopia;BMC Health Services Research;2024-08-06

3. Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis;Journal of Affective Disorders;2024-07

4. Efficacy and safety of peri-partum Esketamine for prevention of post-partum depression in women undergoing caesarian section: A meta-analysis and systematic review of randomized controlled trials;Asian Journal of Psychiatry;2024-07

5. Polish standard of treatment with racemic ketamine for patients with depressive disorders developed by a Working Group appointed by the National Consultant in the field of psychiatry;Psychiatria Polska;2024-06-30